Create an additional Medicare benefit option, coverage of the cost of immunosuppressive drugs, for kidney transplant patients who have no other health insurance or drug coverage
Charge beneficiaries a premium for the new drug-only benefit
Estimated budgetary effects would primarily stem from
Premiums paid by beneficiaries who enroll in the new drug-only coverage
New spending for prescription drugs for beneficiaries who enroll
Reduced spending on other Medicare services
Areas of significant uncertainty include
The number of beneficiaries who would enroll in the new benefit
